IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: April 2024

Volume 9 | Issue 4

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Method Development & Validation for Simultaneous Estimation of Emtricitabine, Rilpivirine & Tenofovir Alafenamide by RP-HPLC Method
Authors Name: Karumudi Vasudha Reddy , Dr. Devanaboyina Narendra , P. Venkata Kishore , Gadi Vijaya Lakshmi
Unique Id: IJSDR2007010
Published In: Volume 5 Issue 7, July-2020
Abstract: A simple, accurate, precise method was developed for the simultaneous estimation of the Emtricitabine, Rilpivirine and Tenofovir Alafenamide by rp-hplc method in bulk and tablet dosage form. Chromatogram was run through Kromasil C18 250x4.6mm, 5m. Mobile phase containing Kh2po4 and Acetonitrile in the ratio of 65:35 v/v was pumped through column at a flow rate of 1ml/min. Temperature was maintained at 30°C. Optimized wavelength for Emtricitabine, Rilpivirine and Tenofovir Alafenamide was 270.00 nm. Retention time of Emtricitabine, Rilpivirine and Tenofovir Alafenamide were found to be 2.212 min, 2.765min and 3.274min. %RSD of system precision for Emtricitabine, Rilpivirine and Tenofovir Alafenamide were and found to be 0.6, 0.8 and 0.5 respectively. %RSD of method precision for Emtricitabine, Rilpivirine and Tenofovir Alafenamide were and found to be 0.5, 0.9 and 0.7 respectively. % recovery was obtained as 99.79%, 100.53% and 99.71% for Emtricitabine, Rilpivirine and Tenofovir Alafenamide respectively. LOD values are obtained from regression equations of Emtricitabine, Rilpivirine and Tenofovir Alafenamide were 1.59ppm, 0.15ppm, 0.16ppm and LOQ values are obtained from regression equations of Emtricitabine, Rilpivirine and Tenofovir Alafenamide were 4.81ppm, 0.45ppm, and 0.46 ppm respectively. Regression equation of Emtricitabine was y = 11254x + 11045. Rilpivirine was y = 9026.8x + 1154.8. and of Tenofovir Alafenamide was y = 16962x + 1751.2. Retention times are decreased so the method developed was simple and economical that can be adopted in regular Quality control test in Industries.
Keywords: Emtricitabine. Rilpivirine, Tenofovir Alafenamide, RP-HPLC
Cite Article: "Method Development & Validation for Simultaneous Estimation of Emtricitabine, Rilpivirine & Tenofovir Alafenamide by RP-HPLC Method", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.5, Issue 7, page no.95 - 102, July-2020, Available :http://www.ijsdr.org/papers/IJSDR2007010.pdf
Downloads: 000337071
Publication Details: Published Paper ID: IJSDR2007010
Registration ID:192053
Published In: Volume 5 Issue 7, July-2020
DOI (Digital Object Identifier):
Page No: 95 - 102
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner